HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bilateral nongranulomatous anterior uveitis associated with bimatoprost.

Abstract
A 72-year-old man with long-standing bilateral glaucoma became refractory to levobunolol ophthalmic solution therapy after many years. Brimonidine was prescribed, but the patient developed a hypersensitivity several months later that was treated with loteprednol ophthalmic suspension. Bimatoprost was initiated 2 weeks later. Within an hour of the first dose of bimatoprost, the patient reported eye pain and photophobia that remained unresolved the following day. Examination revealed acute bilateral nongranulomatous anterior uveitis that was effectively treated with loteprednol. While observations in human and animal models suggest an association between certain prostaglandin-like agents and intraocular inflammation, this report is one of the first to suggest a link between bimatoprost and intraocular inflammatory reaction.
AuthorsMark Packer, I Howard Fine, Richard S Hoffman
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 29 Issue 11 Pg. 2242-3 (Nov 2003) ISSN: 0886-3350 [Print] United States
PMID14670442 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amides
  • Antihypertensive Agents
  • Lipids
  • Cloprostenol
  • Bimatoprost
Topics
  • Aged
  • Amides
  • Antihypertensive Agents (adverse effects)
  • Bimatoprost
  • Cloprostenol (analogs & derivatives)
  • Glaucoma (drug therapy)
  • Humans
  • Intraocular Pressure
  • Lipids (adverse effects)
  • Male
  • Uveitis, Anterior (chemically induced)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: